Found 0 matching trials
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly PHASE4 The study was designed to investigate the optimal management of hyperglycem...
Show More Location
Diabetes and Endocrine Associates La Mesa Location
Learn More & Join Trial
Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome PHASE2 Dumping Syndrome consists of (1) a too rapid gastric emptying, (2) an inapp...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache PHASE2 The purpose of this study was to determine if SOM230 is safe and effective ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors PHASE2 Study evaluating SOM230 in patients with metastatic carcinoid tumors...
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly PHASE2 Acromegaly is a rare, serious condition characterized by chronic hypersecre...
Show More Location
Cedars Sinai Medical Center Dept. of Pituitary Ctr.
Learn More & Join Trial
Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery PHASE4 Postprandial hyperinsulinemic hypoglycemia is a well-known and potentially ...
Show More Location
Zealand University Hospital
Learn More & Join Trial
A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma PHASE1 This study will evaluate the preliminary safety, pharmacokinetics, and anti...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma PHASE2 The purpose of this study is to estimate the time to disease progression wh...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome PHASE2 multi-center, phase II study evaluating efficacy, safety and pharmacokineti...
Show More Location
Ximed Center for Weight Management Ximed Research
Learn More & Join Trial